Ondansetron HCL 4 MG tablet 500S
Ended Awarded Last action
- Contract number
- SPE2DR26FJH9Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,971
Award facts
- Contract value 100% obligated
- $10,970.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,970.68 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (500 units) on January 14, 2026, with an ultimate completion date of January 15, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is Conshohocken, Pennsylvania, AmerisourceBergen's headquarters location. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems.
This delivery order falls under AmerisourceBergen's comprehensive $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical, designated as SPE2DX and extending through December 2026. This prime contract vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. Ondansetron, an anti-nausea medication commonly used in medical settings, exemplifies the critical pharmaceutical commodities distributed through this arrangement to support Department of Defense and other federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FJH9Q?
SPE2DR26FJH9Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FJH9Q worth?
The government has obligated $10,971 on SPE2DR26FJH9Q.
Is contract SPE2DR26FJH9Q an order under another contract?
Yes. SPE2DR26FJH9Q is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJH9Q competed?
The extent of competition for SPE2DR26FJH9Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award